المؤلفون: Wilkins, Deidre¹, Hamrén, Ulrika Wählby², Yue Chang³, Clegg, Lindsay E.⁴, Domachowske, Joseph⁵, Englund, Janet A.⁶, Muller, William J.⁷, Leach, Amanda⁸, Kelly, Elizabeth J.¹, Villafana, Tonya⁸ Tonya.Villafana@astrazeneca.com

المصدر: Pediatrics. Nov2024, Vol. 154 Issue 5, p1-13. 15p.

مصطلحات موضوعية: *PALIVIZUMAB, *PLACEBOS, *RESEARCH funding, *IMMUNOGLOBULINS, *STATISTICAL sampling, *RESPIRATORY syncytial virus infections, *RANDOMIZED controlled trials, *MONOCLONAL antibodies, *TIME

المصدر: A Phase 3, Multicenter, Randomized, Partially Blinded, Palivizumab- Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of MK-1654 in Infants and Children at Increased Risk for Severe RSV Disease

Other URLs: http://engagezone.msd.com/ds_documentation.php

المؤلفون: Altasciences Company Inc.

المصدر: A Phase 1, Double-Blind, Placebo-Controlled, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of PALI-2108 in Healthy Volunteers and Open-Label Study of a Patient Cohort With Ulcerative Colitis

المؤلفون: Bjelica, Milena^1,2 milena.bjelica@mf.uns.ac.rs, Dautović, Gordana Vilotijević^1,2, Spasojević, Slobodan^1,2, Đermanović, Marija², Plazačić, Milica²

المصدر: Iranian Journal of Neonatology. Apr2024, Vol. 15 Issue 2, p3-12. 10p.

مصطلحات موضوعية: *RESPIRATORY syncytial virus infections, *PALIVIZUMAB, *BRONCHOPULMONARY dysplasia, *GESTATIONAL age, *PREMATURE labor

Alternate Title: Research progresses of vaccine and neutralizing antibody of respiratory syncytial virus. (English)

المؤلفون: 崔代迅, 杨小慧, 冯振卿

المصدر: Journal of Nanjing Medical University: Natural Sciences; 2024, Vol. 44 Issue 12, p1763-1772, 10p

مصطلحات موضوعية: RESPIRATORY syncytial virus infection vaccines, RESPIRATORY syncytial virus, CHILD mortality, RESPIRATORY infections, PALIVIZUMAB, MONOCLONAL antibodies

المؤلفون: Teresa Jackowska, August Wrotek, Iwona Beń-Skowronek, Łukasz Dembiński, Tomasz Jarmoliński, Artur Mazur, Anna Medyńska, Katarzyna Plata-Nazar, Jan Styczyński, Tomasz Szczepański, Ewa Toporowska-Kowalska, Piotr Hartmann, Hanna Czajka, Jarosław Peregud-Pogorzelski

المصدر: Pediatria Polska, Vol 99, Iss 4, Pp 275-282 (2024)

مصطلحات موضوعية: respiratory syncytial virus, rsv, palivizumab, abrysvo, nirsevimab, Pediatrics, RJ1-570

وصف الملف: electronic resource

Relation: https://www.termedia.pl/Prevention-of-respiratory-syncytial-virus-infection-in-children-Recommendations-of-the-Polish-Society-of-Paediatrics-and-the-National-Paediatric-Consultant,127,55428,1,1.html; https://doaj.org/toc/0031-3939; https://doaj.org/toc/2300-8660

URL الوصول: https://doaj.org/article/737fa9567b76487183a92a88b6daf79d

المؤلفون: Clara Esperanza Galvis

المصدر: Infectio, Vol 28, Iss 3, Pp 180-191 (2024)

مصطلحات موضوعية: virus sincitial respiratorio, palivizumab, recién nacido prematuro, displasia broncopulmonar, síndrome down, fibrosis quística, Therapeutics. Pharmacology, RM1-950, Infectious and parasitic diseases, RC109-216

وصف الملف: electronic resource

Relation: https://doaj.org/toc/0123-9392

URL الوصول: https://doaj.org/article/403966893e34442ab668c4b2213dc737

المؤلفون: Hepworth, Susan¹ info@infanthealth.org, Goldstein, Mitchell²

المصدر: Neonatology Today. Apr2024, Vol. 19 Issue 4, p83-85. 3p.

مصطلحات موضوعية: *PALIVIZUMAB, *RESPIRATORY syncytial virus infections, *CATASTROPHIC illness, *INFANT care, *MONOCLONAL antibodies, *VIRAL vaccines, *CHILDREN

الشركة/الكيان: UNITED States. Food & Drug Administration

المؤلفون: Emanuel, Hina, Yadav, Aravind, Eapan, Julie C., Caldas-Vasquez, Maria, Harris, Tomika S., McBeth, Katrina, Boricha, Fatima, John, Janice, Magana Ceballos., Ivan G., Colasurdo, Giuseppe N., Tellez, Maria E., Reddy, Tina, De Jesús-Rojas, Wilfredo, Mosquera, Ricardo A.

المصدر: Children; Oct2024, Vol. 11 Issue 10, p1171, 7p

مصطلحات موضوعية: CROSS infection prevention, HOME care services, PALIVIZUMAB, RESEARCH funding, PATIENTS, CHRONIC diseases in children, EVALUATION of human services programs, HOSPITAL care, STATISTICAL sampling, HOSPITAL admission & discharge, RESPIRATORY syncytial virus infections, EVALUATION of medical care, RANDOMIZED controlled trials, DESCRIPTIVE statistics, LONGITUDINAL method, ODDS ratio, MEDICAL appointments, RESEARCH methodology, ARTIFICIAL respiration, DATA analysis software, CONFIDENCE intervals

مصطلحات جغرافية: TEXAS

المؤلفون: Edirisinghe, Hasindu S.^1,2 (AUTHOR) hasindu.edirisinghe@mcri.edu.au, Rajapaksa, Anushi E.^1,2,3,4 (AUTHOR) magdy.sourial@mcri.edu.au, Royce, Simon G.⁵ (AUTHOR) simon.royce@monash.edu, Sourial, Magdy^1,3 (AUTHOR) jeremy.anderson@mcri.edu.au, Bischof, Robert J.⁶ (AUTHOR) r.bischof@federation.edu.au, Anderson, Jeremy^1,2 (AUTHOR) gulcan.sarila@mcri.edu.au, Sarila, Gulcan^1,2 (AUTHOR) cattram.nguyen@mcri.edu.au, Nguyen, Cattram D.¹ (AUTHOR) kim.mulholland@lshtm.ac.uk, Mulholland, Kim^1,2 (AUTHOR) lienanhha.do@mcri.edu.au, Do, Lien Anh Ha^1,2 (AUTHOR), Licciardi, Paul V.^1,2 (AUTHOR) paul.licciardi@mcri.edu.au

المصدر: Viruses (1999-4915). Nov2023, Vol. 15 Issue 11, p2276. 9p.

مصطلحات موضوعية: *RESPIRATORY syncytial virus infections, *PALIVIZUMAB, *LAMBS, *RESPIRATORY syncytial virus, *INTRAMUSCULAR injections, *IMMUNOGLOBULINS, *MONOCLONAL antibodies

المؤلفون: Qianqian Li, Huan Li, Zhihua Li, Youchun Wang

المصدر: MedComm, Vol 5, Iss 12, Pp n/a-n/a (2024)

مصطلحات موضوعية: nirsevimab, palivizumab, prefusion protein, respiratory syncytial virus, structure‐based vaccine, ziresovir, Medicine

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2688-2663

URL الوصول: https://doaj.org/article/abef984f597a4765af92df273ad0e844

المؤلفون: Mark D. Lyttle, Helen Groves, Thomas C. Williams, Simon B. Drysdale, Ian Sinha, Xinxue Liu, Steve Cunningham, Dalia Iskander, Abigail Maxwell-Hodkinson, Shaun O'Hagan, Olivia V. Swann, Chengetai D. Mpamhanga, Damian Roland, Thomas Waterfield, Robin Marlow

المصدر: Wellcome Open Research, Vol 6 (2024)

مصطلحات موضوعية: COVID-19, Respiratory Syncytial Virus, Bronchiolitis, Infants, Children, Palivizumab, eng, Medicine, Science

وصف الملف: electronic resource

Relation: https://wellcomeopenresearch.org/articles/6-120/v4; https://doaj.org/toc/2398-502X

URL الوصول: https://doaj.org/article/90cef1f8bbcc4de7804c48e38eef2e45

المؤلفون: Moritz Wick, Roman Kliemt, Anahita Poshtiban, Nils Kossack, Gerhard-Paul Diller, Samira Soudani, Mathieu Bangert, Rolf Kramer, Oliver Damm

المصدر: Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)

مصطلحات موضوعية: Respiratory syncytial virus, infants, immunization, palivizumab, claims analysis, Germany, Immunologic diseases. Allergy, RC581-607, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2164-5515; https://doaj.org/toc/2164-554X

URL الوصول: https://doaj.org/article/bcae42cc822e4687a30261ed7010f125

المؤلفون: Bergeron, Harrison C, Murray, Jackelyn, Arora, Aakash, Castrejon, Ana M Nuñez, DuBois, Rebecca M, Anderson, Larry J, Kauvar, Lawrence M, Tripp, Ralph A

المصدر: Viruses. 15(5)

مصطلحات موضوعية: Microbiology, Biological Sciences, Prevention, Pediatric, Vaccine Related, Pneumonia & Influenza, Lung, Biotechnology, Immunization, Infectious Diseases, Pneumonia, Development of treatments and therapeutic interventions, 5.1 Pharmaceuticals, Infection, Mice, Humans, Animals, Aged, Palivizumab, Antibodies, Viral, Viral Fusion Proteins, Respiratory Syncytial Virus, Human, Respiratory Syncytial Virus Infections, Antibodies, Monoclonal, Epitopes, RSV, G protein, F protein, mAb, 3D3, 2D10, palivizumab

URL الوصول: https://escholarship.org/uc/item/67g5197m

المؤلفون: Keary, Ian P.¹ (AUTHOR), Ravasio, Roberto² (AUTHOR), Fullarton, John R.¹ (AUTHOR), Manzoni, Paolo^3,4 (AUTHOR), Lanari, Marcello⁵ (AUTHOR), Paes, Bosco A.⁶ (AUTHOR), Carbonell-Estrany, Xavier⁷ (AUTHOR), Baraldi, Eugenio^8,9 (AUTHOR), Tarride, Jean-Éric^6,10 (AUTHOR), Rodgers-Gray, Barry¹ (AUTHOR) barry@violicom.co.uk

المصدر: PLoS ONE. 8/10/2023, Vol. 18 Issue 9, p1-19. 19p.

مصطلحات موضوعية: *RESPIRATORY syncytial virus infections, *PALIVIZUMAB, *ITALIANS, *COST effectiveness, *GESTATIONAL age

Alternate Title: Prevention of respiratory syncitial virus (RSV) in infants: A minor revolution?

المؤلفون: Veluzat, Simon¹ (AUTHOR) s.veluzat@mspb.com

المصدر: Médecine Thérapeutique: Pédiatrie. jul-dec2023, Vol. 25 Issue 3/4, p172-176. 5p.

مصطلحات موضوعية: *PALIVIZUMAB, *RESPIRATORY syncytial virus infections, *ANTIVIRAL agents, *RESPIRATORY syncytial virus, *IMMUNOGLOBULINS

المؤلفون: Naruhiko Ishiwada, Rina Akaishi, Yasuhiro Kobayashi, Kanae Togo, Naohiro Yonemoto, Moe Matsuo, Shinnosuke Kaneko, Amy W. Law, Kazumasa Kamei

المصدر: Infectious Diseases and Therapy, Vol 13, Iss 7, Pp 1665-1682 (2024)

مصطلحات موضوعية: Cost-effectiveness analysis, Japan, Palivizumab, Respiratory syncytial virus, RSVpreF, Vaccination, Infectious and parasitic diseases, RC109-216

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2193-8229; https://doaj.org/toc/2193-6382

URL الوصول: https://doaj.org/article/e4484d8b1a2844a6a518eae7db045f8b

المصدر: FANTASY-A Randomised, Double-Blind, 3-arm Parallel Study to Compare the Pharmacokinetics, Safety, Immunogenicity and Tolerability of MB05 (Proposed Palivizumab Biosimilar), EU-sourced Synagis® and US-sourced Synagis®, Administered as a Single Dose Intramuscular Injection in Healthy Volunteers.

المصدر: A Phase 2/3 Randomized, Double-blind, Palivizumab-controlled Study to Evaluate the Safety of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in High-risk Children (MEDLEY)
Domachowske J, Madhi SA, Simoes EAF, Atanasova V, Cabanas F, Furuno K, Garcia-Garcia ML, Grantina I, Nguyen KA, Brooks D, Chang Y, Leach A, Takas T, Yuan Y, Griffin MP, Mankad VS, Villafana T; MEDLEY Study Group. Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity. N Engl J Med. 2022 Mar 3;386(9):892-894. doi: 10.1056/NEJMc2112186. No abstract available.

Other URLs: https://astrazenecagroup-dt.pharmacm.com/DT/Home

المؤلفون: Suryadevara, Manika

المصدر: Journal of the Pediatric Infectious Diseases Society; 2024 Supplement, Vol. 13, pS110-S114, 5p

مصطلحات موضوعية: IMMUNIZATION, PLACENTA, MATERNALLY acquired immunity, RESPIRATORY infections, MATERNAL age, HEALTH status indicators, PALIVIZUMAB, IMMUNOGLOBULINS, MOTHERS, RESPIRATORY syncytial virus infections, CATASTROPHIC illness, PREGNANT women, NUTRITIONAL requirements, MONOCLONAL antibodies, GESTATIONAL age, BIRTH weight, IMMUNOCOMPETENCE, DISEASE risk factors, CHILDREN